Home » Steven Tregay

Steven Tregay

Jun 21, 2007
Premium
Cequent Pharmaceuticals said this week that Steven Tregay has been appointed to the company’s board of directors.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Skipped Steps

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

Just a Few Bats

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

This Week in Nature

In Nature this week: investigation into the genetics of medulloblastoma, and more.

Genomics for the Trees

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.

What's Popular?

In Gene Silencing/Gene Editing

  1. UC Riverside Team Wins $14.9M DARPA Grant for Genetic Mosquito Control Research

  2. Bio-Rad Laboratories Aims to Create Genome Editing Tools Pipeline, Starting With ddPCR

    Premium

  3. Researchers Design, Construct Genome-Wide Sequence-Verified Arrayed CRISPR Library

  4. Christiana Care, NovellusDx Ink Licensing Deal for Gene-Editing Tech

  5. Cas1-Cas2 Integrase Structures Enable Bacteria to Adapt to New Viruses

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.